Shandong Pharmaceutical Glass Co Ltd Cash Flow Reinvestment Rate
Shandong Pharmaceutical Glass Co Ltd cash flow reinvestment rate. Shandong Pharmaceutical Glass Co Ltd (600529) has a Cash Flow Reinvestment Rate of 5.03x as of December 2025, reinvesting CN¥208.74 Million (capex CN¥153.18 Million plus investments CN¥55.56 Million) from operating cash flow of CN¥41.46 Million. Explore 600529 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Shandong Pharmaceutical Glass Co Ltd (2001–2025)
Cash flow reinvestment rate of Shandong Pharmaceutical Glass Co Ltd from 2001 to 2025. Historical reinvestment intensity for Shandong Pharmaceutical Glass Co Ltd across 24 annual periods. Explore capital reinvestment ratio of Shandong Pharmaceutical Glass Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Shandong Pharmaceutical Glass Co Ltd Cash Flow Reinvestment Rate by Year (2001–2025)
Shandong Pharmaceutical Glass Co Ltd cash flow reinvestment rate by year from 2001 to 2025. Year-by-year capital reinvestment analysis for Shandong Pharmaceutical Glass Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Shandong Pharmaceutical Glass Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | CN¥311.94 Million | CN¥576.92 Million | CN¥231.86 Million | ▼ -43.7% |
| 2024 | 0.96x | CN¥1.12 Billion | CN¥1.17 Billion | CN¥647.79 Million | ▼ -29.0% |
| 2023 | 1.35x | CN¥1.42 Billion | CN¥1.05 Billion | CN¥671.53 Million | ▼ -77.4% |
| 2022 | 5.97x | CN¥1.51 Billion | CN¥252.44 Million | CN¥710.71 Million | ▲ +407.1% |
| 2021 | 1.18x | CN¥883.26 Million | CN¥750.44 Million | CN¥809.26 Million | ▼ -12.9% |
| 2020 | 1.35x | CN¥765.20 Million | CN¥566.01 Million | CN¥535.20 Million | ▼ -11.9% |
| 2019 | 1.54x | CN¥919.69 Million | CN¥599.05 Million | CN¥591.69 Million | ▼ -1.7% |
| 2018 | 1.56x | CN¥727.38 Million | CN¥465.77 Million | CN¥347.38 Million | ▲ +32.0% |
| 2017 | 1.18x | CN¥487.24 Million | CN¥411.96 Million | CN¥167.06 Million | ▲ +102.9% |
| 2016 | 0.58x | CN¥295.25 Million | CN¥506.53 Million | CN¥196.58 Million | ▲ +22.7% |
| 2015 | 0.48x | CN¥185.12 Million | CN¥389.63 Million | CN¥155.12 Million | ▼ -5.1% |
| 2014 | 0.50x | CN¥133.53 Million | CN¥266.63 Million | CN¥133.53 Million | ▼ -10.6% |
| 2013 | 0.56x | CN¥150.49 Million | CN¥268.60 Million | CN¥150.49 Million | ▼ -86.9% |
| 2012 | 4.28x | CN¥122.10 Million | CN¥28.52 Million | CN¥122.10 Million | ▲ +440.5% |
| 2011 | 0.79x | CN¥217.53 Million | CN¥274.63 Million | CN¥217.53 Million | ▼ -14.2% |
| 2010 | 0.92x | CN¥200.37 Million | CN¥217.01 Million | CN¥200.37 Million | ▲ +94.3% |
| 2009 | 0.48x | CN¥118.44 Million | CN¥249.27 Million | CN¥118.44 Million | ▼ -72.5% |
| 2008 | 1.73x | CN¥158.40 Million | CN¥91.76 Million | CN¥158.40 Million | ▲ +31.6% |
| 2007 | 1.31x | CN¥160.82 Million | CN¥122.63 Million | CN¥160.82 Million | ▲ +45.8% |
| 2006 | 0.90x | CN¥70.59 Million | CN¥78.47 Million | CN¥70.59 Million | ▼ -53.4% |
| 2005 | 1.93x | CN¥85.09 Million | CN¥44.09 Million | CN¥85.09 Million | ▼ -57.8% |
| 2003 | 4.58x | CN¥271.74 Million | CN¥59.35 Million | CN¥271.74 Million | ▲ +344.7% |
| 2002 | 1.03x | CN¥112.49 Million | CN¥109.26 Million | CN¥112.49 Million | ▲ +16.3% |
| 2001 | 0.89x | CN¥25.32 Million | CN¥28.60 Million | CN¥25.32 Million | — |